Details of the Drug Formulations

General Information of Drug (ID: DMYGJQO)

Drug Name
Ponatinib Drug Info
Synonyms Iclusig (TN)
Indication
Disease Entry ICD 11 Status REF
Acute lymphoblastic leukaemia 2A85 Approved [1]
Chronic myelogenous leukaemia 2A20.0 Approved [2]
Thyroid tumor Approved [2]
Cross-matching ID
PubChem CID
24826799
ChEBI ID
CHEBI:78543
CAS Number
943319-70-8
TTD ID
D0H0EQ
VARIDT ID
DR00204
INTEDE ID
DR1315
ACDINA ID
D00541

Full List of Drug Formulations Containing This Drug

Ponatinib Hydrochloride eq 10mg base tablet
Company Formulation ID FDA Description
Ariad F23984 Lactose Monohydrate; Microcrystalline Cellulose; Sodium Starch Glycolate (Type B); Colloidal Silicon Dioxide; Magnesium Stearate; Talc; Polyethylene Glycol; Polyvinyl Alcohol; Titanium Dioxide
------------------------------------------------------------------------------------
Ponatinib Hydrochloride eq 15mg base tablet
Company Formulation ID FDA Description
Ariad F23985 Lactose Monohydrate; Microcrystalline Cellulose; Sodium Starch Glycolate (Type B); Colloidal Silicon Dioxide; Magnesium Stearate; Talc; Polyethylene Glycol; Polyvinyl Alcohol; Titanium Dioxide
------------------------------------------------------------------------------------
Ponatinib Hydrochloride eq 30mg base tablet
Company Formulation ID FDA Description
Ariad F23986 Lactose Monohydrate; Microcrystalline Cellulose; Sodium Starch Glycolate (Type B); Colloidal Silicon Dioxide; Magnesium Stearate; Talc; Polyethylene Glycol; Polyvinyl Alcohol; Titanium Dioxide
------------------------------------------------------------------------------------
Ponatinib Hydrochloride eq 45mg base tablet
Company Formulation ID FDA Description
Ariad F23987 Lactose Monohydrate; Microcrystalline Cellulose; Sodium Starch Glycolate (Type B); Colloidal Silicon Dioxide; Magnesium Stearate; Talc; Polyethylene Glycol; Polyvinyl Alcohol; Titanium Dioxide
------------------------------------------------------------------------------------
Ponatinib 15 mg tablet
Company Formulation ID FDA Description
ARIAD Pharmaceuticals; Millennium Pharmaceuticals F17362 Lactose monohydrate; Magnesium stearate; Silicon dioxide; Microcrystalline cellulose; Sodium starch glycolate type b potato
------------------------------------------------------------------------------------
Ponatinib 30 mg tablet
Company Formulation ID FDA Description
ARIAD Pharmaceuticals; Millennium Pharmaceuticals F17363 Lactose monohydrate; Magnesium stearate; Silicon dioxide; Microcrystalline cellulose; Sodium starch glycolate type b potato
------------------------------------------------------------------------------------
Ponatinib 45 mg tablet
Company Formulation ID FDA Description
ARIAD Pharmaceuticals; Millennium Pharmaceuticals F17364 Lactose monohydrate; Magnesium stearate; Silicon dioxide; Microcrystalline cellulose; Sodium starch glycolate type b potato
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5890).
2 Ponatinib FDA Label